Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
生達化學製藥股份有限公司二廠 (TW)
ATC Code
G04CA01
Source
TFDA
USDailyMed:Alfuzosin
AU:B2
G04CA01(WHO)
UK:POM(Prescription only)US:℞-only
(RS)-N-[3-[(4-Amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide
81403-80-7Y
2092
7109
DB00346Y
2008Y
90347YTW5F
D07124Y
CHEBI:51141Y
ChEMBL709Y
DTXSID6048549
Interactive image
O=C(NCCCN(c2nc1cc(OC)c(OC)cc1c(n2)N)C)C3OCCC3
InChI=1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)YKey:WNMJYKCGWZFFKR-UHFFFAOYSA-NY
Alfuzosin, sold under the brand nameUroxatralamong others, is amedicationof theα1blockerclass. It is used to treatbenign prostatic hyperplasia(BPH).
As anantagonistof theα1-adrenergic receptor, it works by relaxing the muscles in theprostateandbladderneck, making urination easier.
⚠️ Warnings
•Caution should be exercised in patients with history of irregular heartbeat, prostate cancer, chest pain, low blood pressure, heart or kidney disease, any allergy, who are taking other medications and children.
Alfuzosin is prescribed only for men .Women must not take this medicine especially during pregnancy and lactation.
Avoid driving a car or operating machinery and get up slowly from bed while taking this medication as it may cause dizziness and lightheadedness.
Avoid situations in which injury could occur because of fainting.
Rarely, it may cause prolonged or painful erection; if so consult your doctor.